{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T20:17:16Z","timestamp":1782764236014,"version":"3.54.5"},"reference-count":75,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>As the question of the pathogenesis of inflammatory myopathies remains unanswered, there has been a significant effort in recent years to investigate various components of the innate and adaptive immune systems, with evidence pointing that they work together to initiate and propagate the autoimmune response. This review aims to explore recent advancements in understanding the mechanisms underlying myopathies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Recent research has concentrated on uncovering potential triggers, examining the role of immune cells, both lymphocytes and myeloids, and investigating the contribution of inflammatory mediators to the autoimmune response in inflammatory myopathies. Unsuccessful clinical trials helped reshape established hypotheses about pathogenesis, while genetic mutations offered clues to the disease's root causes. The pathogenic role of autoantibodies is being reconsidered based on transcriptional data. Repurposing existing medications to combat muscle fiber dysfunction is also emerging as a potential therapeutic approach.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Our understanding of inflammatory myopathies has evolved significantly as our understanding of the disease has grown. Even though breakthroughs have been documented on the underlying mechanisms of myopathies, important questions remain unanswered.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000001077","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T10:00:08Z","timestamp":1739440808000},"page":"192-198","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["An update on the pathogenesis of idiopathic inflammatory myopathies"],"prefix":"10.1097","volume":"37","author":[{"given":"Eleni","family":"Tiniakou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"R1-20250326","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis: (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"R2-20250326","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis: (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"R3-20250326","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R4-20250326","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12016-015-8511-x","article-title":"Idiopathic inflammatory myopathies and malignancy: a comprehensive review","volume":"52","author":"Tiniakou","year":"2017","journal-title":"Clinic Rev Allerg Immunol"},{"key":"R5-20250326","doi-asserted-by":"crossref","first-page":"e150201","DOI":"10.1172\/JCI150201","article-title":"Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence","volume":"132","author":"Fiorentino","year":"2022","journal-title":"J Clin Invest"},{"key":"R6-20250326","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1093\/rheumatology\/keab166","article-title":"A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies","volume":"60","author":"Oldroyd","year":"2021","journal-title":"Rheumatology"},{"key":"R7-20250326","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/art.42311","article-title":"Subsets of idiopathic inflammatory myositis enriched for contemporaneous cancer relative to the general population","volume":"75","author":"Mecoli","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"R8-20250326","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1126\/science.1246886","article-title":"Association of the autoimmune disease scleroderma with an immunologic response to cancer","volume":"343","author":"Joseph","year":"2014","journal-title":"Science"},{"key":"R9-20250326","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/rheumatology\/kex413","article-title":"Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis","volume":"57","author":"Pinal-Fernandez","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"R10-20250326","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/art.42474","article-title":"Association of anti-CCAR1 autoantibodies with decreased cancer risk relative to the general population in patients with anti-transcriptional intermediary factor 1\u03b3-positive dermatomyositis","volume":"75","author":"Fiorentino","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"R11-20250326","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/ard-2022-222441","article-title":"Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1\u03b3 autoantibodies","volume":"82","author":"Hosono","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R12-20250326","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/acr2.11750","article-title":"The relationship between anti-cell division cycle and apoptosis regulator 1 autoantibodies, anti-Sp4 autoantibodies, and cancer in anti-transcription intermediary factor 1\u03b3-positive dermatomyositis","volume":"12","author":"Mecoli","year":"2024","journal-title":"ACR Open Rheumatol"},{"key":"R13-20250326","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11926-020-00942-3","article-title":"Lipid-lowering therapies in myositis","volume":"22","author":"Mizus","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"R14-20250326","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R15-20250326","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R16-20250326","doi-asserted-by":"crossref","first-page":"e2217831120","DOI":"10.1073\/pnas.2217831120","article-title":"Limb girdle muscular disease caused by HMGCR mutation and statin myopathy treatable with mevalonolactone","volume":"120","author":"Yogev","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"R17-20250326","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ajhg.2023.04.006","article-title":"Bi-allelic variants in HMGCR cause an autosomal-recessive progressive limb-girdle muscular dystrophy","volume":"110","author":"Morales-Rosado","year":"2023","journal-title":"Am J Hum Genet"},{"key":"R19-20250326","doi-asserted-by":"crossref","first-page":"e001202","DOI":"10.1136\/rmdopen-2020-001202","article-title":"Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease","volume":"6","author":"Nishina","year":"2020","journal-title":"RMD Open"},{"key":"R20-20250326","doi-asserted-by":"crossref","first-page":"R214","DOI":"10.1186\/ar3547","article-title":"Epidemiologic study of clinically amyopathic dermatomyositis and antimelanoma differentiation-associated gene 5 antibodies in central Japan","volume":"13","author":"Muro","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R21-20250326","doi-asserted-by":"crossref","first-page":"837024","DOI":"10.3389\/fmed.2022.837024","article-title":"Seasonal effect on disease onset and presentation in anti-MDA5 positive dermatomyositis","volume":"9","author":"So","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R22-20250326","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3899\/jrheum.220259","article-title":"Antimelanoma differentiation-associated gene 5 antibody-positive interstitial lung disease after vaccination with COVID-19 mRNA vaccines","volume":"49","author":"Kitajima","year":"2022","journal-title":"J Rheumatol"},{"key":"R23-20250326","doi-asserted-by":"crossref","first-page":"105136","DOI":"10.1016\/j.ebiom.2024.105136","article-title":"MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C)","volume":"104","author":"David","year":"2024","journal-title":"EBioMedicine"},{"key":"R24-20250326","first-page":"395","article-title":"COVID-19 linked to rise in anti-MDA5 autoimmunity","volume":"20","author":"McHugh","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"R25-20250326","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/acr2.11423","article-title":"Presence and implications of anti-angiotensin converting enzyme-2 immunoglobulin M antibodies in anti-melanoma-differentiation-associated 5 dermatomyositis","volume":"4","author":"Mecoli","year":"2022","journal-title":"ACR Open Rheumatol"},{"key":"R26-20250326","doi-asserted-by":"crossref","first-page":"e11752","DOI":"10.1002\/acr2.11752","article-title":"Comprehensive enteroviral serology links infection and anti-melanoma differentiation-associated protein 5 dermatomyositis","volume":"7","author":"Jayaraman","year":"2025","journal-title":"ACR Open Rheumatol"},{"key":"R27-20250326","doi-asserted-by":"crossref","first-page":"1279055","DOI":"10.3389\/fimmu.2023.1279055","article-title":"TCR\u03b2 clones in muscle tissue share structural features in patients with idiopathic inflammatory myopathy and are associated with disease activity","volume":"14","author":"Anang","year":"2023","journal-title":"Front Immunol"},{"key":"R28-20250326","doi-asserted-by":"crossref","first-page":"e17240","DOI":"10.15252\/emmm.202217240","article-title":"Single-cell profiling of muscle-infiltrating T cells in idiopathic inflammatory myopathies","volume":"15","author":"Argyriou","year":"2023","journal-title":"EMBO Mol Med"},{"key":"R29-20250326","doi-asserted-by":"crossref","first-page":"104804","DOI":"10.1016\/j.ebiom.2023.104804","article-title":"Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies","volume":"96","author":"Leclair","year":"2023","journal-title":"EBioMedicine"},{"key":"R30-20250326","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13075-020-02397-4","article-title":"Expansion of circulating peripheral TIGIT+CD226+ CD4\u200aT cells with enhanced effector functions in dermatomyositis","volume":"23","author":"Li","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"R31-20250326","doi-asserted-by":"crossref","first-page":"e200143","DOI":"10.1212\/NXI.0000000000200143","article-title":"Upregulation of the CD155-CD226 axis is associated with muscle inflammation and disease severity in idiopathic inflammatory myopathies","volume":"10","author":"Li","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R32-20250326","doi-asserted-by":"crossref","first-page":"e176963","DOI":"10.1172\/jci.insight.176963","article-title":"Coordinated immune dysregulation in juvenile dermatomyositis revealed by single-cell genomics","volume":"9","author":"Rabadam","year":"2024","journal-title":"JCI Insight"},{"key":"R33-20250326","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/art.42446","article-title":"Association of juvenile dermatomyositis disease activity with the expansion of blood memory B and T cell subsets lacking follicular markers","volume":"75","author":"Gofshteyn","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"R34-20250326","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1084\/jem.20070081","article-title":"Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease","volume":"204","author":"Sather","year":"2007","journal-title":"J Exp Med"},{"key":"R35-20250326","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/acr.21671","article-title":"Increased frequency of DRB1\u221711:01 in antihydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy","volume":"64","author":"Mammen","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R37-20250326","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1073\/pnas.0236183100","article-title":"Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR, and CDR3-spectratype analysis","volume":"100","author":"Hofbauer","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R38-20250326","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1084\/jem.181.5.1863","article-title":"T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8+ T cells","volume":"181","author":"Bender","year":"1995","journal-title":"J Exp Med"},{"key":"R39-20250326","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1172\/JCI118749","article-title":"Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis","volume":"97","author":"Goebels","year":"1996","journal-title":"J Clin Invest"},{"key":"R40-20250326","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/brain\/awg114","article-title":"Muscle fibres and cultured muscle cells express the B7.1\/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies","volume":"126","author":"Wiendl","year":"2003","journal-title":"Brain"},{"key":"R41-20250326","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s004010000324","article-title":"Immunolocalization of FAS and FAS ligand in inflammatory myopathies","volume":"101","author":"De Bleecker","year":"2001","journal-title":"Acta Neuropathol"},{"key":"R42-20250326","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas","year":"2015","journal-title":"N Engl J Med"},{"key":"R43-20250326","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1096\/fj.09-144782","article-title":"Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies","volume":"24","author":"Grundtman","year":"2010","journal-title":"FASEB J"},{"key":"R44-20250326","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/art.20220","article-title":"Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids","volume":"50","author":"Ulfgren","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R45-20250326","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41467-021-27875-4","article-title":"Targeting necroptosis in muscle fibers ameliorates inflammatory myopathies","volume":"13","author":"Kamiya","year":"2022","journal-title":"Nat Commun"},{"key":"R46-20250326","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/art.42071","article-title":"Contribution of necroptosis to myofiber death in idiopathic inflammatory myopathies","volume":"74","author":"Peng","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R47-20250326","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/rheumatology\/keab753","article-title":"Plasma exosomal RNAs have potential as both clinical biomarkers and therapeutic targets of dermatomyositis","volume":"61","author":"Li","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"R48-20250326","doi-asserted-by":"crossref","first-page":"791986","DOI":"10.3389\/fcell.2022.791986","article-title":"Endoplasmic reticulum stress is involved in muscular pathogenesis in idiopathic inflammatory myopathies","volume":"10","author":"Ma","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"R49-20250326","doi-asserted-by":"crossref","first-page":"228","DOI":"10.21037\/atm-22-70","article-title":"Autophagy-related genes are potential diagnostic biomarkers for dermatomyositis","volume":"10","author":"Wang","year":"2022","journal-title":"Ann Transl Med"},{"key":"R50-20250326","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-cell therapy in autoimmune disease \u2013 a case series with follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N Engl J Med"},{"key":"R51-20250326","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/acr2.11521","article-title":"Transcriptome profiling of immune cell types in peripheral blood reveals common and specific pathways involved in the pathogenesis of myositis-specific antibody-positive inflammatory myopathies","volume":"5","author":"Sugimori","year":"2023","journal-title":"ACR Open Rheumatol"},{"key":"R52-20250326","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/jleuko\/qiae083","article-title":"Novel B-cell subsets as potential biomarkers in idiopathic inflammatory myopathies: insights into disease pathogenesis and disease activity","volume":"116","author":"Reyes-Huerta","year":"2024","journal-title":"J Leukoc Biol"},{"key":"R53-20250326","doi-asserted-by":"crossref","first-page":"902232","DOI":"10.3389\/fimmu.2022.902232","article-title":"Multi-modal single-cell sequencing identifies cellular immunophenotypes associated with juvenile dermatomyositis disease activity","volume":"13","author":"Neely","year":"2022","journal-title":"Front Immunol"},{"key":"R55-20250326","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/gene.2015.28","article-title":"Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes","volume":"16","author":"Miller","year":"2015","journal-title":"Genes Immun"},{"key":"R56-20250326","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/annrheumdis-2015-208119","article-title":"Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups","volume":"75","author":"Rothwell","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R57-20250326","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/annrheumdis-2019-215046","article-title":"Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups","volume":"78","author":"Rothwell","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R58-20250326","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/art.42972","article-title":"Muscle tissue transcriptome of idiopathic inflammatory myopathy reflects the muscle damage process by monocytes and presence of skin lesions","volume":"77","author":"Izuka","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"R59-20250326","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/art.42283","article-title":"Imaging mass cytometry reveals predominant innate immune signature and endothelial\u2013immune cell interaction in juvenile myositis compared to lupus skin","volume":"74","author":"Turnier","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R60-20250326","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41598-021-04302-8","article-title":"Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactive","volume":"12","author":"Roberson","year":"2022","journal-title":"Sci Rep"},{"key":"R61-20250326","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/archderm.1978.01640160014004","article-title":"Epidermal nucleolar IgG deposition in clinically normal skin: clinical and serologic features of eight patients","volume":"114","author":"Prystowsky","year":"1978","journal-title":"Arch Dermatol"},{"key":"R62-20250326","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archderm.1978.01640170005001","article-title":"Speckled (particulate) epidermal nuclear IgG deposition in normal skin. Correlation of clinical features and laboratory findings in 46 patients with a subset of connective tissue disease characterized by antibody to extractable nuclear antigen","volume":"114","author":"Prystowsky","year":"1978","journal-title":"Arch Dermatol"},{"key":"R63-20250326","first-page":"787","article-title":"More severe disease and slower recovery in younger patients with anti3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy","volume":"56","author":"Tiniakou","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R64-20250326","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.30344","article-title":"Correlation of antisignal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy","volume":"63","author":"Benveniste","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R65-20250326","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromusc Disord"},{"key":"R66-20250326","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/annrheumdis-2018-213518","article-title":"In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy","volume":"78","author":"Bergua","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R67-20250326","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/S2665-9913(23)00003-6","article-title":"Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial","volume":"5","author":"Mammen","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"R68-20250326","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s004010050462","article-title":"Cytochrome c oxidase deficiencies in the muscle of patients with inflammatory myopathies","volume":"91","author":"Chariot","year":"1996","journal-title":"Acta Neuropathol"},{"key":"R69-20250326","first-page":"615","article-title":"Mitochondrial abnormalities in dermatomyositis: characteristic pattern of neuropathology","volume":"35","author":"Alhatou","year":"2004","journal-title":"J Mol Histol"},{"key":"R70-20250326","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/ard.54.6.491","article-title":"Respiratory chain enzyme defects in patients with idiopathic inflammatory myopathy","volume":"54","author":"Campos","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"R71-20250326","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/clin.1998.4527","article-title":"Cell death and oxidative damage in inflammatory myopathies","volume":"87","author":"Tews","year":"1998","journal-title":"Clin Immunol Immunopathol"},{"key":"R72-20250326","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1038\/s41467-024-49460-1","article-title":"IFN\u03b3 causes mitochondrial dysfunction and oxidative stress in myositis","volume":"15","author":"Abad","year":"2024","journal-title":"Nat Commun"},{"key":"R73-20250326","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/jcsm.13025","article-title":"Amelioration of inflammatory myopathies by glucagon-like peptide-1 receptor agonist via suppressing muscle fibre necroptosis","volume":"13","author":"Kamiya","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R74-20250326","doi-asserted-by":"crossref","first-page":"103061","DOI":"10.1016\/j.jaut.2023.103061","article-title":"Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis","volume":"138","author":"Duvvuri","year":"2023","journal-title":"J Autoimmun"},{"key":"R76-20250326","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/rheumatology\/kead186","article-title":"Effect of type I interferon on engineered pediatric skeletal muscle: a promising model for juvenile dermatomyositis","volume":"63","author":"Covert","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"R77-20250326","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.jid.2021.02.748","article-title":"Highly multiplexed mass cytometry identifies the immunophenotype in the skin of dermatomyositis","volume":"141","author":"Patel","year":"2021","journal-title":"J Invest Dermatol"},{"key":"R78-20250326","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/art.42050","article-title":"Identification of similarities between skin lesions in patients with antisynthetase syndrome and skin lesions in patients with dermatomyositis by highly multiplexed imaging mass cytometry","volume":"74","author":"Patel","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R79-20250326","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/jamadermatol.2023.4744","article-title":"Rapid improvement in recalcitrant cutaneous juvenile dermatomyositis with anifrolumab treatment","volume":"160","author":"Shaw","year":"2024","journal-title":"JAMA Dermatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T19:45:42Z","timestamp":1743277542000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001077","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]}}}